Falconer, Karolin <br/><br/>
IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.  [electronic resource] 

 -  Scandinavian journal of infectious diseases  Dec 2010 
 - 896-901 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-1980 
<br/><br/><label>Standard No.: </label>10.3109/00365548.2010.498019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Chemokine CXCL10--blood<br/>Drug Therapy, Combination--methods<br/>Female<br/>HIV Infections--complications<br/>Hepacivirus<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Male<br/>Middle Aged<br/>Prognosis<br/>RNA, Viral--blood<br/>Treatment Outcome<br/>Viral Load